Skip to content
ARTHEx biotech
  • About us
  • Our products
  • Pipeline
    • Publications
  • Team/Investors
  • Contact/Events
  • News

J.P. MORGAN

July 24, 2020February 26, 2019 by Abel Rodriguez

January 2019:

ARTHEx S.L. participation at the 37th Annual J.P. Morgan Healthcare Conference, celebrated from January 7 to 10 2019 in San Francisco, California.

Participation at the 37th Annual J. P. Morgan

Share this post
  • Share on Facebook
  • Tweet on Twitter
Categories News
Post navigation
BIO International Convention
International Myotonic Dystrophy Consortium

Arthex on Twitter

AvatarARTHEx biotech@Arthexbiotech·

Today is a dar Out of office to work in our team. #teamworkmakesthedreamwork

Retweet on TwitterARTHEx biotech Retweeted
AvatarTranslational Genomics Lab University of Valencia@GenomicsLab_UV·

Can you help on this? @incliva_iis @DM1research @DM1Steinert @UV_EG https://twitter.com/MyotonicStrong/status/1417174433765072913

AvatarARTHEx biotech@Arthexbiotech·

Hemos hecho un nuevo vídeo sobre cómo el RNA puede ayudar a tratar la Distrofia miotónica. https://www.youtube.com/watch?v=K3AETZ6MsRI

AvatarARTHEx biotech@Arthexbiotech·

Hace unos días participamos en la jornada “Presente y Futuro del desarrollo de tratamientos para la DM1” os dejamos por aquí el link https://www.asem-esp.org/noticias/preguntas-y-respuestas-sobre-la-distrofia-miotonica-tipo-1-o-enfermedad-de-steinert/

Load More...

News

  • We are delighted to announce a new addition to our growing team, Sheila Soriano May 25, 2021
  • Different awards and grants recognize ARTHEx’s efforts to start up an innovative treatment for DM1 November 28, 2020
  • Eric Marcusson joins ARTHEx’s  Scientific Advisory Board November 2, 2020
  • Dr Nicholas Jonhson, new Chief Medical Advisor August 28, 2020
  • Arthex secures €4.25M from Invivo Ventures and Advent France Biotechnology July 24, 2020
Logo blanco
Drug discovery in neuromuscular diseases
ARTHEX BIOTECH. S.L
C/ Catedrático Agustín Escardino 9 – 46980 Paterna, Valencia (Spain)
Telephone: +34 625 016 629 – E-mail:  info@arthexbiotech.com
Linkedin   Facebook   Twitter
logo innivierte
logo Ministerio de Ciencia e Innovación
eit
European Union
Logo de la Generalitat
IVACE
Logotipo neotec
IV(F)* Institut Valencià de Finances
© 2021 ARTHEx biotech • Built with GeneratePress
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read MoreACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT